Stock market update: Nifty Pharma index falls 0.79% in an upbeat market

NEW DELHI:  The Nifty Pharma index traded negative around 10:19AM(IST)on Tuesday in an upbeat market.

Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon Ltd.(up 0.41 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.03 per cent) were among the top gainers.

Dr. Reddy’s Laboratories Ltd.(down 3.1 per cent), Ipca Laboratories Ltd.(down 2.58 per cent), Aurobindo Pharma Ltd.(down 2.0 per cent), Ajanta Pharma Ltd.(down 1.87 per cent) and Granules India Ltd.(down 1.86 per cent) were the top losers on the index.

The Nifty Pharma index was down 0.79 per cent at 21599.05 at the time of writing this report.

Benchmark NSE Nifty50 index was up 147.66 points at 23806.0, while the BSE Sensex was up 552.08 points at 78536.46.

Among the 50 stocks in the Nifty index, 35 were trading in the green, while 15 were in the red.

Shares of Vodafone Idea, IREDA, YES Bank, Suzlon Energy and Ola Electric Mobilit were among the most traded shares on the NSE.

Shares of Cura Tech, Mahamaya Steel, Jupiter Life Line Hospitals, Bohra Industries and SBI Card hit their fresh 52-week highs in today’s trade, while Shrem InvIT, Sanco Industries, AGS Transact Tech, Marshall Machines and Praxis Home Retail hit fresh 52-week lows in trade.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March